Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute, New York 10032, USA.
Biol Psychiatry. 2010 Oct 1;68(7):634-41. doi: 10.1016/j.biopsych.2010.05.027. Epub 2010 Jul 31.
Alterations in dopamine D(2)/D(3) receptor binding have been reported in schizophrenia, and a meta-analysis of imaging studies has shown a modest elevation in striatum. Newer radioligands now allow the assessment of these receptors in extrastriatal regions. We used positron emission tomography with [(18)F]fallypride to evaluate D(2)/D(3) receptors in both striatal and extrastriatal regions in schizophrenia.
Twenty-one patients with schizophrenia and 22 matched healthy control subjects were scanned with an ECAT EXACT HR+ camera. Two-tissue compartment modeling and the reference tissue method gave binding potentials relative to nondisplaceable uptake, total plasma concentration, and free plasma concentration. These were compared between groups in five striatal and eight extrastriatal regions. Several regional volumes were lower in the patient group, and positron emission tomography data were corrected for partial volume effects.
Binding potential values differed in three regions between groups. Values for binding potential relative to nondisplaceable uptake from two-tissue compartment modeling in patients and control subjects, respectively, were 28.7 ± 6.8 and 25.3 ± 4.3 in postcommissural caudate, 2.9 ± .7 and 2.6 ± .4 in thalamus, and 1.8 ± .5 and 2.1 ± .7 in uncus. Loss of D(2)/D(3) receptors with age was found in striatal and extrastriatal regions and was greater in neocortex.
Our study found selective alterations in D(2)/D(3) receptors in striatal and extrastriatal regions, consistent with some but not all previously published reports. As previously shown for the striatum, a more sensitive imaging approach for studying the role of dopamine in the pathophysiology of schizophrenia might be assessment of neurotransmitter levels rather than D(2)/D(3) receptor levels in extrastriatal regions.
精神分裂症患者的多巴胺 D2/D3 受体结合发生改变,影像学研究的荟萃分析显示纹状体有适度升高。新型放射性配体现在可以评估这些受体在纹状体以外区域的情况。我们使用 [(18)F]fallypride 正电子发射断层扫描评估精神分裂症患者的纹状体和纹状体以外区域的 D2/D3 受体。
21 例精神分裂症患者和 22 例匹配的健康对照者接受 ECAT EXACT HR+ 相机扫描。双室模型和参照组织法给出了与不可置换摄取、总血浆浓度和游离血浆浓度相关的结合潜能。在 5 个纹状体区域和 8 个纹状体以外区域将这些结果在两组之间进行比较。患者组的几个区域体积较低,正电子发射断层扫描数据进行了部分容积效应校正。
两组间有三个区域的结合潜能值不同。双室模型的结合潜能值分别为患者和对照组的后连合尾状核 28.7±6.8 和 25.3±4.3,丘脑 2.9±0.7 和 2.6±0.4,和钩回 1.8±0.5 和 2.1±0.7。纹状体和纹状体以外区域的 D2/D3 受体随年龄减少,而新皮层减少更明显。
我们的研究发现,纹状体和纹状体以外区域的 D2/D3 受体选择性改变,与一些但不是所有先前的报告一致。如先前在纹状体中所示,研究多巴胺在精神分裂症病理生理学中的作用的更敏感的成像方法可能是评估神经递质水平而不是纹状体以外区域的 D2/D3 受体水平。